Studies have shown that B2M expression levels do not appear to be affected by hypoxia [51], as hypoxia is not the cause of B2M degradation and may be used as a specific biomarker for early screening, treatment and prognosis of highland pulmonary edema in plateau areas. Here, B2M is linked to pulmonary edema.